Octagon Capital Advisors as of June 30, 2024
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 44 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Call Option (APLS) | 19.5 | $124M | 3.2M | 38.36 | |
| Insmed Com Par $.01 Call Option (INSM) | 9.5 | $60M | 900k | 67.00 | |
| Dianthus Therapeutics (DNTH) | 7.1 | $45M | 1.7M | 25.88 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 7.0 | $45M | 1.1M | 39.27 | |
| Dyne Therapeutics (DYN) | 6.5 | $42M | 1.2M | 35.29 | |
| Arrivent Biopharma (AVBP) | 5.3 | $34M | 1.8M | 18.55 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.3 | $27M | 1.9M | 14.46 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 3.5 | $22M | 488k | 45.25 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.3 | $21M | 2.3M | 9.03 | |
| Bridgebio Pharma (BBIO) | 2.7 | $18M | 690k | 25.33 | |
| Ocular Therapeutix (OCUL) | 2.6 | $17M | 2.4M | 6.84 | |
| Perspective Therapeutics Com New (CATX) | 2.5 | $16M | 1.6M | 9.97 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.4 | $16M | 2.2M | 7.21 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.7 | $11M | 260k | 41.36 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.6 | $10M | 4.6M | 2.24 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.5 | $9.5M | 1.1M | 8.70 | |
| Terns Pharmaceuticals (TERN) | 1.5 | $9.3M | 1.4M | 6.81 | |
| Gossamer Bio (GOSS) | 1.3 | $8.3M | 9.2M | 0.90 | |
| Miragen Therapeutics (VRDN) | 1.3 | $8.1M | 620k | 13.01 | |
| Tenaya Therapeutics (TNYA) | 1.3 | $8.0M | 2.6M | 3.10 | |
| Regulus Therapeutics (RGLS) | 1.2 | $7.6M | 4.3M | 1.78 | |
| Allovir (ALVR) | 1.1 | $7.1M | 9.8M | 0.72 | |
| Mineralys Therapeutics (MLYS) | 1.1 | $7.0M | 600k | 11.70 | |
| An2 Therapeutics (ANTX) | 1.1 | $6.9M | 3.2M | 2.15 | |
| Akero Therapeutics (AKRO) | 1.0 | $6.6M | 283k | 23.46 | |
| Jasper Therapeutics Com New (JSPR) | 1.0 | $6.5M | 288k | 22.70 | |
| Pepgen (PEPG) | 0.9 | $6.0M | 376k | 15.96 | |
| Ventyx Biosciences (VTYX) | 0.9 | $5.5M | 2.4M | 2.31 | |
| Cybin Ord (CYBN) | 0.8 | $5.0M | 19M | 0.27 | |
| Century Therapeutics (IPSC) | 0.5 | $3.4M | 1.3M | 2.55 | |
| Reneo Pharmaceuticals (RPHM) | 0.5 | $3.4M | 2.3M | 1.51 | |
| Silence Therapeutics Ads (SLN) | 0.5 | $3.3M | 176k | 19.00 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.4 | $2.6M | 250k | 10.22 | |
| Poseida Therapeutics I (PSTX) | 0.3 | $2.1M | 736k | 2.92 | |
| Elevation Oncology (ELEV) | 0.3 | $2.0M | 747k | 2.70 | |
| Mersana Therapeutics (MRSN) | 0.3 | $2.0M | 992k | 2.01 | |
| Annexon (ANNX) | 0.3 | $2.0M | 400k | 4.90 | |
| Fate Therapeutics (FATE) | 0.3 | $1.7M | 521k | 3.28 | |
| Nkarta (NKTX) | 0.2 | $1.4M | 240k | 5.91 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $1.3M | 432k | 2.92 | |
| Adicet Bio (ACET) | 0.1 | $929k | 768k | 1.21 | |
| Rapt Therapeutics (RAPT) | 0.1 | $891k | 292k | 3.05 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $773k | 465k | 1.66 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $613k | 176k | 3.48 |
